Good day, and welcome to the IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025. The next presenting company is Scienture Holdings, Inc. [Operator Instructions] I would now like to ...

CMAB promotes four accomplished individuals who have played vital roles in advancing CMAB’s mission to support California’s ...

Atossa Therapeutics, Inc. ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative therapies in areas of significant unmet need in breast cancer, today announced ...

Most project briefs center on the what—the task, the deliverable, the output. But without a shared understanding of why we’re ...

MidSolid, formerly known as Custom Soap Colorado and Rocky Mountain Body Works & Co., has announced significant enhancements to its manufacturing capabilities for solid shampoo and conditioner bars, ...

Artificial intelligence is often hailed as a game changer, but too many firms discover that their bold AI pilots collapse ...

Founder transitions are pivotal moments that can either propel a company into its next phase of growth or stall its momentum ...

The Nutraceutical Excipients Market was valued at USD 4.5 billion in 2024, reflecting strong expansion driven by the rising consumption of dietary supplements and functional nutrition products. As ...

SoluPet, the data and science-driven pet cognitive health company developing advanced cognitive-aging support for senior dogs ...

From luxury hotel spas to modern hammams and zero-proof bars, Madrid’s wellness renaissance is reshaping how locals and ...

ORLANDO, FLORIDA / ACCESS Newswire / December 5, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company leveraging proprietary exosome-based delivery systems, today announced ...

Identifies Biomarker Signature Predicting Sensitivity To IV Sapu003. Oncotelic Therapeutics (OTCQB: OTLC), reports that its 45% owned joint venture, Sapu Nano, has identified a High-RICTOR/Low-RPTOR ...